InvestorsHub Logo
Post# of 251718
Next 10
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: bladerunner1717 post# 210273

Wednesday, 03/29/2017 2:39:13 PM

Wednesday, March 29, 2017 2:39:13 PM

Post# of 251718
MAXY continued to incur R&D costs through the JV with Astellas. The gene-shuffling technology was eventually sold to MAXY’s spin-off, CDXS for essentially nothing (#msg-56059056).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.